Rarebase

Rarebase is a true drug development biotechnology platform that is revolutionizing the drug discovery and development process at an unprecedented speed, scale, and capital efficiency. Rarebase is committed to improving the lives of 400 million rare disease patients worldwide. With a product engine designed to simultaneously discover treatments for hundreds of monogenic diseases, Rarebase focuses on the largest untapped drug discovery opportunity in human health: rare diseases. Rarebase has already identified potential treatments for hundreds of rare diseases. The company has also developed a "Drug Genome Map" to enable AI-driven drug discovery. Rarebase is headquartered in Palo Alto, California.